Carrie L. Bourdow, Director at Nabriva Therapeutics plc (NBRV), sold 777 shares at $1.20 ($932) on 2021-08-02, disclosed to the SEC on 2021-08-04.
Open-market sale of $932 NBRV by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TRVN | BUY | 2016-11-10 | $17K | — | Filing → |